1. Bio-tech biz proposal Life-maximizing is Future

2. ContentsA.CompanyB.TechnologyC.MarketD.ProductsE.Biz StrategyF.Financial ProjectionG.APPENDIX 3. A. Company1. CIEtymology() VITA() VITA , , , . MAX()Maximum Maximizing , VITAMAX()(Vita) (Max) , (Vita) (Max) .Color RedRGB(100, 0, 0) Red VITAMAX . . 4. A. Company 2. Legal EntityVITAMAX limited(Hong Kong no.1137363)RM 2208B, 22th/F, Tower 1, China Hong Kong City, 33 Canton Road,Tsim Sha Tsui, Kowloon, Hong Kong (+852-8124-5114); Holding and financial management entity for Chinese business(China no.0966215)Bio-Valley 4F, National Health Technology Park,ZhongShan, GuangDong, China (Tel. +86-760-826-1907 / +86-134-2701-0202); R&D and Manufacturing center in Main land; Going to be renamed to VITAMAX bio-pharm() 5. A. Company 3. Members, ( ) - - - (www.dimete.com)CEO , ( B.A. / MBA) - , CA, South Baylo Univ. , Anatomy/Physiology - NTech9, CTO - Cosmos Fund, (www.cosmosfund.com) - VITAMAX company, CEOCTO , ( / / ) - , - , - , [Wang, WeiDong] (, ) - - , - , BCH, ()OEM , [Piao, WenHua] - , , - , BCH, OEM / 6. A. Company4. NHTP introNHTP(Natinonal Health Technology Park in ZhonShan) () 660s.m(200) () . . . , . http://www.nhtp.gov.cn 7. A. Company 5. R&D center ( US$6)VITAMAX R&D center 1) Hybaid()THERMAL REACTOR NHTP (Bio-valley) 4F 2) Perkin Elmer(USA) DNA THERMAL CYCLER 2sets GMP .3) Serono(USA) SEROZYME I 4) Heraeus() 5) Bio Hazard(USA) BIO HAZARD CABINET 6) Hanil(Korea)Brushless DC Moter Centrifuge: 990 m7) Perkin Elmer(USA) AUTODELFIA(Automatic Immunoassay System)1) GMP: 150 m 8) Perkin Elmer(USA) CHEMICAL ANALYEZER2) : 350m9) Hanil HMR-210(Korea) 10) IEC(USA) IEC HN-SII Centrifuge3) : 150m 11) TGL(Taiwan)TGL-16M 4) : 125m 12) Anke(china)TDL-5-A 5) (, , , ):13) Sunshin(China) 215m 14) Xinxing(China) 2sets 15) Segwang(Korea) ROTATOR 16) DDS-IIA(China) Conductivity meter 17) 205B(China) 18) CIMO(China) 2sets 19) 101A-IE(China) 20) (China) 4sets 21) Satorius() Master Flex 8. B. Technology1. (STEM CELL) , , , , . VITAMAX SN21 injection ,(ES, Embryonic Stem cells) (CNS stemcell) . SN21 injection stem cells , . CNS stem cell . 9. B. Technology1. , . , . , , (cell replacement therapy) . . 10. B. Technology1. (Placenta) Umbricus (Amnion) , , SN21 injection . , , (cell replacement therapy) . . 11. B. Technology2. Type () . , . . , . , . , . 2 .Type 21 , . Type 21Type I Collagen : skin, muscle, blood vessels Type XI Collagen : cartilageType II Collagen :cartilage Type XII Collagen : tendon, fibril associated collagenType III Collagen : skin, tendon, blood vessel, boneType XIII Collagen : epidermis, hair follicles, nail root cellsType IV Collagen : artery, capillaryType XIV Collagen : fibril associated collagenType V Collagen :basement membrane. interstitial spaceType XV Collagen : many tissues, homology toType VI Collagen : liver, kidney, perichondrium,Type XVI Collagen : under study interstitial tissuesType VII Collagen : epidermal /dermal juction Type XVII Collagen : hemidesmosomes, skinType VIII Collagen : endothelial cell Type XVIII Collagen : liver, endostainType IX Collagen : cartilageType XIX Collagen : eyes, brain, testes, embryonic tissueType X Collagen : hypertrophic and mineralizing cartilage Type XX Collagen : under studyType XXI Collagen : under study 12. B. Technology2. Type Type Type I&III Type II . , Type . ( , Type . OEM )VITAMAX Type Type I, III Type II Type XIII Type XIX ( 9 , .) 13. C. Market1. Placenta BarrierPlacenta () , . . DMF , DMF B-GMP K-GMP . DMF(Drug Master File) 2002 7 , , , , , - , . 14. C. Market 2. Placenta Injections (Placenta Injections) (, 1956 ) : , Copy (, 1959 ) : - (Swiss, Placenta Lucchini)1992 , Placenta Injection , Injection , . 20073 300 ( report ) 15. C. Market3. Cosmetics() Approach Concept( )No! C2K(China to Korea), , ( ) Yes! K2C(Korea to China), , / . , , BCH , (95%) , .Design , , , . , , 16. C. Market3. Cosmetics() Approach () - , . 100~800/ , . - , . , . - . , . 80~90% . - , . . , . - , . . , , .VITAMAX BCH . BCH , / (RMB 4000/ 1) . 17. D. Products1. CosmeticsEvangelion Line (EVA, [AiBo]) for Professionals & Home CareEVA-R(enewal, ) . . , Eva () , () . EVA-R .EVA-F(lat, ) ( ) . EVA-W , .EVA-W(hite, ) Formula . .EVA-P(ack, ) , . EVA-P EVA . 18. D. Products2. Food DrinkEva-D ( )EVA() Drink (Type) , . Eva-D . (liver) , .VITAGEN [ShengJian] AntiAging Placenta Injection Drink . . () .SMARTGEN [XueJian] Drink Trend. needs 19. D. Products3. Food Capsule & Sugar-CoatedVITAGEN [ShengJian]Anti-Aging HGH , , , , ,, , , , , . ,, .POWERGEN [LiJian] Type XIX(19) . ( ) . 20. D. Products 4. Placenta VITAMAX Placenta Injection , . 1930 . 1950 . , , , , , , , , , . .Placenta Placenta / , / , , / , , , / , , , , Placenta / . Placenta . 21. D. Products 4. Placenta VITAMAX The best way (5) . Placenta . , . Lucchini Lab. Placenta . / . 24 .( Placenta VITAMAX Lucchini OEM .) 22. D. Products 4. Hyaluronic Acid(Hyaluronic Acid, H.A. )H.A. , , ph 1) () . 2) ( ) . 3) H.A. 4)() H.A. . 5)() , 80 6)(, ) . 7)() 8)(, ) . 9)DDS( : , ) H.A. 10) 11) Tissue engineering() . H.A 12) . H.A. , . H.A. 13) (, , ) , . H.A., VITAMAX H.A. H.A. . , . VITAMAX H.A. , , .. 23. D. Products 4. Products under developmentType [MaoJian] - Type XIII Drink ( ) . . (, ) - . . OEM . 24. E. Biz strategy 1. Big picture VITAMAX VITAMAX VITAMAX / VITAMAX / 5 // 5 // (or NASDAQ) (or NASDAQ) / / / / , , (Eva line) (,1~4) (,1~4) FDA FDA (Eva line) Drink / / (ex> Drink (ex> (, )( ) ( ) VITALADY) (, ) VITALADY) ( ( M&A (as Merger) M&A (as Merger))) VITAMAX VITAMAX 1 123( 2010 )( 2007 )( 2009 ) 25. E. Biz strategy 2. Wellbeing Mkt concentration , , / Anti-Aging / / 26. E. Biz strategy 2. Product Steps segment / . 1) (ex> / . cf> M&A .) 2) ( segment segment Funding ) 3) ( ) 4) 5) ( Drink / ) 27. F. Financial Projection 1. Sales Projection Projection8,000,0007,000,0006,000,000 150,0005,000,000 100,00050,000 4,000,000 -() 1 ()3,000,000 2,000,0001,000,000 ( US$ ) -20072008 2009 28. F. Financial Projection2. Investment Projection Step , 2006 (, ) . , , . US$20~30 , (Evangelion ) . () . , , OEM . US$350 , OEM . . , Placenta VITAMAX , ( ) . , , , Step IR . 29. G. APPENDIX1. Entity Documents 30. G. APPENDIX1. Pictures